New research suggests that oral drugs for erectile dysfunction (ED) don’t increase a man’s risk for biochemical recurrence of prostate cancer. The term “biochemical recurrence” refers to the possibility that prostate cancer has come back after treatment. This occurs when a PSA (prostate-specific antigen) test shows that PSA levels have increased. Elevated PSA levels are not always a sign of...